Lesson 11: DNA technology Chapter 1: Restriction enzymes & DNA ligase Key points: • • • • Restriction enzymes are DNA-cutting enzymes. Each enzyme recognizes one or a few target sequences and cuts DNA at or near those sequences. Many restriction enzymes make staggered cuts, producing ends with singlestranded DNA overhangs. However, some produce blunt ends. DNA ligase is a DNA-joining enzyme. If two pieces of DNA have matching ends, ligase can link them to form a single, unbroken molecule of DNA. In DNA cloning, restriction enzymes and DNA ligase are used to insert genes and other pieces of DNA into plasmids. How do you cut and paste DNA? In DNA cloning, researchers make many copies of a piece of DNA, such as a gene. In many cases, cloning involves inserting the gene into a piece of circular DNA called a plasmid, which can be copied in bacteria. How can pieces of DNA from different sources (such as a human gene and a bacterial plasmid) be joined together to make a single DNA molecule? One common method is based on restriction enzymes and DNA ligase. • A restriction enzyme is a DNA-cutting enzyme that recognizes specific • sites in DNA. Many restriction enzymes make staggered cuts at or near their recognition sites, producing ends with a single-stranded overhang. If two DNA molecules have matching ends, they can be joined by the enzyme DNA ligase. DNA ligase seals the gap between the molecules, forming a single piece of DNA. Restriction enzymes and DNA ligase are often used to insert genes and other pieces of DNA into plasmids during DNA cloning. Restriction enzymes Restriction enzymes are found in bacteria (and other prokaryotes). They recognize and bind to specific sequences of DNA, called restriction sites. Each restriction enzyme recognizes just one or a few restriction sites. When it finds its target sequence, a restriction enzyme will make a double-stranded cut in the DNA molecule. Typically, the cut is at or near the restriction site and occurs in a tidy, predictable pattern. Why do bacteria have restriction enzymes? As an example of how a restriction enzyme recognizes and cuts at a DNA sequence, let's consider EcoRI, a common restriction enzyme used in labs. EcoRI cuts at the following site: When EcoRI recognizes and cuts this site, it always does so in a very specific pattern that produces ends with single-stranded DNA “overhangs”: If another piece of DNA has matching overhangs (for instance, because it has also been cut by EcoRI), the overhangs can stick together by complementary base pairing. For this reason, enzymes that leave single-stranded overhangs are said to produce sticky ends. Sticky ends are helpful in cloning because they hold two pieces of DNA together so they can be linked by DNA ligase. Not all restriction enzymes produce sticky ends. Some are “blunt cutters,” which cut straight down the middle of a target sequence and leave no overhang. The restriction enzyme SmaI is an example of a blunt cutter: Blunt-ended fragments can be joined to each other by DNA ligase. However, blunt-ended fragments are harder to ligate together (the ligation reaction is less efficient and more likely to fail) because there are no single-stranded overhangs to hold the DNA molecules in position. Where do restriction enzymes get these weird names? DNA ligase If you’ve learned about DNA replication, you may already have met DNA ligase. In DNA replication, ligase’s job is to join together fragments of newly synthesized DNA to form a seamless strand. The ligases used in DNA cloning do basically the same thing. If two pieces of DNA have matching ends, DNA ligase can join them together to make an unbroken molecule. How does DNA ligase do this? Using ATP as an energy source, ligase catalyzes a reaction in which the phosphate group sticking off the 5’ end of one DNA strand is linked to the hydroxyl group sticking off the 3’ end of the other. This reaction produces an intact sugar-phosphate backbone. Example: Building a recombinant plasmid Let's see how restriction digestion and ligation can be used to insert a gene into a plasmid. Suppose we have a target gene, flanked with EcoRI recognition sites, and a plasmid, containing a single EcoRI site: Our goal is to use the enzyme EcoRI to insert the gene into the plasmid. First, we separately digest (cut) the gene fragment and the plasmid with EcoRI. This step produces fragments with sticky ends: Next, we take the gene fragment and the linearized (opened-up) plasmid and combine them along with DNA ligase. The sticky ends of the two fragments stick together by complementary base pairing: Once they are joined by ligase, the fragments become a single piece of unbroken DNA. The target gene has now been inserted into the plasmid, making a recombinant plasmid. Restriction digests and ligations involve many molecules of DNA In the example above, we saw one outcome of a ligation between a gene and plasmid cut with EcoRI. However, other outcomes could happen in this exact same ligation. For instance, the cut plasmid could recircularize (close back up) without taking in the gene. Similarly, the gene could go into the plasmid, but flipped backwards (since its two EcoRI sticky ends are identical). Restriction digests and ligations like this one are performed using many copies of plasmid and gene DNA. In fact, billions of molecules of DNA are used in a single ligation! These molecules are all bumping into one another, and into DNA ligase, at random in different ways. So, if multiple products can be made, all of them will be made at some frequency – including ones we don't want. How can we avoid the "bad" plasmids? When we transform bacteria with DNA from a ligation, each one takes up a different piece of DNA. We can check the bacteria after transformation and use only the ones with the correct plasmid. In many cases, plasmid from transformed bacteria is analyzed using another restriction digest to see if it contains the right insert in the right orientation. Chapter 2: Stem cells Stem cells are the foundation of all complex biological organisms, possessing the unique ability to self-renew and differentiate into various specialized cell types. Their role in development, tissue regeneration, and disease treatment has made them a critical focal point of modern biomedical research. When combined with advancements in DNA technology, stem cells offer unprecedented opportunities in personalized medicine, gene therapy, and regenerative medicine. What Are Stem Cells? Stem cells are undifferentiated cells capable of both self-renewal (producing more stem cells) and differentiation (developing into specialized cell types). There are two main types: 1. Embryonic Stem Cells (ESCs): Derived from early-stage embryos, ESCs are pluripotent, meaning they can differentiate into almost any cell type in the body. 2. Adult Stem Cells: Found in various tissues such as bone marrow and skin, adult stem cells are typically multipotent, meaning they can differentiate into a limited range of cell types related to their tissue of origin. Additionally, induced pluripotent stem cells (iPSCs), generated by reprogramming adult somatic cells to an embryonic-like state, have emerged as a powerful tool in DNA technology and regenerative medicine. DNA technology has dramatically expanded the possibilities of stem cell research and application. Image from Wikimedia Here are some key ways stem cells can influence the field of DNA technology: 1. Gene Editing in Stem Cells: CRISPR-Cas9 is a revolutionary tool for precise genome editing. It works by using a small RNA molecule (guide RNA) to locate a specific DNA sequence in the genome, and the Cas9 enzyme acts as molecular scissors to cut the DNA at this targeted location. Once the DNA is cut, the cell's natural repair mechanisms respond to the DNA at that site. If researchers provide a synthetic DNA template with desired changes, the cell can use it to insert, modify, or correct the sequence at the cut site. When applied to stem cells, CRISPR-Cas9 technology enables researchers to correct genetic mutations that cause disease or to introduce therapeutic genes. Hematopoietic (blood) stem cells (HSCs), for instance, are prime candidates for gene therapy. With DNA technology, scientists can alter HSCs to express therapeutic genes, offering potential cures for blood disorders like thalassemia or leukemia. 2. Stem Cells for Disease Modeling and Drug Discovery: Stem cells derived from patient-specific iPSCs allow for the creation of individualized disease models. These cells can be differentiated into specific tissues that mimic the patient’s condition, offering a platform to test drug responses and to study disease progression at the cellular level. In diseases like Parkinson’s, for instance, where neurons are affected, iPSCs from patients can be differentiated into dopaminergic neurons to study the disease’s mechanisms and test therapeutic interventions. Stem cells combined with advanced DNA technology enable high-throughput drug screening. Using stem cell-derived tissues, researchers can test thousands of compounds for their effectiveness and safety in treating specific conditions, thus accelerating drug discovery. 3. Regenerative Medicine and Tissue Engineering: DNA technology can modify stem cells to enhance their regenerative capacities. By using gene editing tools, scientists can program stem cells to promote tissue repair or to generate specific tissues for transplantation. For example, researchers are exploring the possibility of using gene-edited stem cells to engineer organs, such as liver or heart tissue, that can be transplanted into patients without the risk of rejection or immune response. Combining stem cells with 3D bioprinting technology allows for the creation of complex tissue structures. Incorporating DNA technology into this process enables the design of tissues with precise genetic modifications, enhancing their functionality and increasing the success of regenerative therapies. 4. Stem Cells and Epigenetic Modifications: DNA technology has enhanced our understanding of how epigenetic modifications (chemical changes to DNA, such as methylation, that affect gene expression without altering the DNA sequence) regulate stem cell differentiation. Epigenetic reprogramming is crucial in converting somatic cells into iPSCs and in directing stem cells to differentiate into specific cell types. By manipulating the epigenetic landscape, scientists can promote or inhibit the differentiation of stem cells into neurons, muscle cells, or other cell types, aiding in the development of targeted therapies for degenerative diseases. Challenges and Ethical Considerations While DNA technology has revolutionized stem cell research, it also presents significant challenges and ethical concerns: 1. Ethical Issues in Gene Editing: Editing the genomes of stem cells that can give rise to reproductive cells raises concerns about unintended consequences on future generations. The potential for "designer babies" or permanent genetic changes to the human species must be carefully regulated. Furthermore, the use of human embryonic stem cells in research continues to spark ethical debates over the destruction of embryos. 2. Off-Target Effects and Safety Concerns: While technologies like CRISPR offer high precision, they can sometimes cause off-target effects, where unintended parts of the genome are altered, leading to potential harmful mutations. Ensuring the safety and accuracy of these techniques remains a key challenge. 3. Immune Rejection: Even with genetically edited stem cells, immune rejection is a major hurdle in stem cell therapies. Using DNA technology to make stem cells immunologically compatible with the patient could help overcome this issue, but this area still requires extensive research. The Future of Stem Cells in DNA Technology The intersection of stem cell biology and DNA technology continues to open new avenues for treating previously untreatable conditions. Advances in gene editing, personalized medicine, and tissue regeneration hold the potential to cure genetic diseases, replace damaged tissues, and revolutionize drug development. The future promises even greater integration of these fields, where therapeutic approaches will be customized to individual patients based on their genetic makeup, ensuring more effective and safer treatments. As DNA technology continues to evolve, its application to stem cell research will push the boundaries of medicine, offering hope for curing diseases at their root cause and fundamentally altering the future of healthcare.
0
You can add this document to your study collection(s)
Sign in Available only to authorized usersYou can add this document to your saved list
Sign in Available only to authorized users(For complaints, use another form )